IFNL2 and depressive symptom measurement: What IL-28A and IL-33 have in common (more specifically, lower concentrations of IL-28A and high concentrations of IL-33) is their expression in neuroinflammatory processes, depression, with and without PTSD, risk of depression as well as in insomnia comorbid with depression [9,11,15,16].